Cargando…
Prevalence of dry eye in patients with systemic lupus erythematosus: a meta-analysis
OBJECTIVES: To investigate dry eye disease (DED) in patients affected by systemic lupus erythematosus (SLE). METHODS: We conducted a systematic search of the literature on PubMed, EMBASE and the Cochrane Library databases from conception to 30 April 2020 for studies related to dry eye, secondary Sjö...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483036/ https://www.ncbi.nlm.nih.gov/pubmed/34588240 http://dx.doi.org/10.1136/bmjopen-2020-047081 |
_version_ | 1784577034594287616 |
---|---|
author | Wang, Lixiang Xie, Yan Deng, Yingping |
author_facet | Wang, Lixiang Xie, Yan Deng, Yingping |
author_sort | Wang, Lixiang |
collection | PubMed |
description | OBJECTIVES: To investigate dry eye disease (DED) in patients affected by systemic lupus erythematosus (SLE). METHODS: We conducted a systematic search of the literature on PubMed, EMBASE and the Cochrane Library databases from conception to 30 April 2020 for studies related to dry eye, secondary Sjögren’s syndrome (sSS) and SLE. Original full-text articles with the number of patients diagnosed with SLE of over 15 were included. The risk of bias was evaluated with a validated critical appraisal tool which assessed study quality based on confounding factors, selection bias, bias related to measurement and bias related to data analysis. Data were extracted and pooled to evaluate the overall prevalence of DED with the random-effect model and sSS with the fixed effect model. RESULTS: A total of 29 studies were included and 18 273 participants were involved. The pooled data showed that the overall prevalence of DED was 16% (95% CI 10% to 21%, p<0.001) in patients of SLE. Dry eye symptoms and abnormal Schirmer’s test were found in 26% (95% CI 20% to 32%, p<0.001) and 24% (95% CI 14% to 34%, p<0.001) of patients with SLE, respectively. 12% (95% CI 9% to 15%, p<0.001) of patients also met the criteria of sSS. The OR of DED in patients with SLE was 4.26 (95% CI 3.47 to 5.05, p<0.001) compared with healthy controls. The meta-regression analysis showed that the sample size (p=0.004) and study location (p=0.022) could be the source of heterogeneity. CONCLUSIONS: DED and sSS are both common in patients with SLE. |
format | Online Article Text |
id | pubmed-8483036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-84830362021-10-08 Prevalence of dry eye in patients with systemic lupus erythematosus: a meta-analysis Wang, Lixiang Xie, Yan Deng, Yingping BMJ Open Rheumatology OBJECTIVES: To investigate dry eye disease (DED) in patients affected by systemic lupus erythematosus (SLE). METHODS: We conducted a systematic search of the literature on PubMed, EMBASE and the Cochrane Library databases from conception to 30 April 2020 for studies related to dry eye, secondary Sjögren’s syndrome (sSS) and SLE. Original full-text articles with the number of patients diagnosed with SLE of over 15 were included. The risk of bias was evaluated with a validated critical appraisal tool which assessed study quality based on confounding factors, selection bias, bias related to measurement and bias related to data analysis. Data were extracted and pooled to evaluate the overall prevalence of DED with the random-effect model and sSS with the fixed effect model. RESULTS: A total of 29 studies were included and 18 273 participants were involved. The pooled data showed that the overall prevalence of DED was 16% (95% CI 10% to 21%, p<0.001) in patients of SLE. Dry eye symptoms and abnormal Schirmer’s test were found in 26% (95% CI 20% to 32%, p<0.001) and 24% (95% CI 14% to 34%, p<0.001) of patients with SLE, respectively. 12% (95% CI 9% to 15%, p<0.001) of patients also met the criteria of sSS. The OR of DED in patients with SLE was 4.26 (95% CI 3.47 to 5.05, p<0.001) compared with healthy controls. The meta-regression analysis showed that the sample size (p=0.004) and study location (p=0.022) could be the source of heterogeneity. CONCLUSIONS: DED and sSS are both common in patients with SLE. BMJ Publishing Group 2021-09-29 /pmc/articles/PMC8483036/ /pubmed/34588240 http://dx.doi.org/10.1136/bmjopen-2020-047081 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Rheumatology Wang, Lixiang Xie, Yan Deng, Yingping Prevalence of dry eye in patients with systemic lupus erythematosus: a meta-analysis |
title | Prevalence of dry eye in patients with systemic lupus erythematosus: a meta-analysis |
title_full | Prevalence of dry eye in patients with systemic lupus erythematosus: a meta-analysis |
title_fullStr | Prevalence of dry eye in patients with systemic lupus erythematosus: a meta-analysis |
title_full_unstemmed | Prevalence of dry eye in patients with systemic lupus erythematosus: a meta-analysis |
title_short | Prevalence of dry eye in patients with systemic lupus erythematosus: a meta-analysis |
title_sort | prevalence of dry eye in patients with systemic lupus erythematosus: a meta-analysis |
topic | Rheumatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483036/ https://www.ncbi.nlm.nih.gov/pubmed/34588240 http://dx.doi.org/10.1136/bmjopen-2020-047081 |
work_keys_str_mv | AT wanglixiang prevalenceofdryeyeinpatientswithsystemiclupuserythematosusametaanalysis AT xieyan prevalenceofdryeyeinpatientswithsystemiclupuserythematosusametaanalysis AT dengyingping prevalenceofdryeyeinpatientswithsystemiclupuserythematosusametaanalysis |